For healthcare & life-science professionals

Want to work in pharma? You may not need an MSc in Clinical Research.

There is a faster, lower-cost route into the industry that hiring managers take seriously: live, industry-led training that leaves you with a portfolio of real deliverables in 6 months, not a £25,000 credential in two years.

Led by Dorothy Ogwuru — 18+ years in pharma, former Global Pharmacovigilance Head.

The £100 call fee is credited in full against your enrolment
6 months|CPD Accredited|Live expert-led sessions|Portfolio in 6 months
Book a strategy call — £100 Or get the £497 Career Report
★★★★★

Verified alumni reviews · Read on Trustpilot →

"PharmaLink gave me the vocabulary, the portfolio and the confidence to walk into an industry interview and actually belong there."

Emeka · Regulatory Medical Writing graduate

"I stopped applying blind. PharmaLink showed me what pharma hiring managers actually look for — and how to show up as that person."

Sasu · Regulatory Medical Writing graduate

"Clinical practice taught me the science. PharmaLink taught me how pharma actually hires, speaks and builds careers — and got me through the door."

Katie · Physician Associate, pharma transition

Where our graduates work

RochePTxCancer Research UKDaiichi-SankyoTakeda

Organisations where PharmaLink Academy alumni are currently employed. Shown for information only; no partnership or endorsement implied.

Dorothy Ogwuru, Founder of PharmaLink Academy

Dorothy Ogwuru · Founder, PharmaLink Academy

From the other side of the hiring table

Most career advice comes from people who never had to make the hiring decision. I have.

As a Global Head of Pharmacovigilance, and now leading a regulatory medical writing consultancy, I have sat on the other side of the table. I have read the CVs, sat on the panels, and decided who progresses and who does not. I ask the interview questions, so I know which answers move a candidate forward and which quietly end the conversation.

Here is the pattern I noticed, again and again. Two people hold the same qualification and get very different outcomes. What separates them is almost never another certificate. It is whether they can show the work: interpret a document, reason through a safety signal, write to the standard a regulator expects. That is what makes a CV worth shortlisting, and it is exactly what an interview is built to expose.

PharmaLink is built backwards from that decision. Not from what a syllabus thinks you should know, but from what I look for when I am the one deciding who to hire.

Professionals who chose the industry route

Every one of these graduates moved into regulatory medical writing, from very different starting points.

Physician Associate
Regulatory Medical Writer

Katie

Pharmacist
Regulatory Medical Writer

Joannita

Life Science graduate
Regulatory Medical Writer

Sasu

Regulatory Affairs
Regulatory Medical Writer

Emeka

This is not a sales argument against the MSc. It is an honest comparison from someone who has hired clinical research staff and built the industry-direct route for people who want to be employable in 6 to 9 months, not 2 years. For some careers the MSc is the right call. For most industry roles, it is not.

An MSc Clinical Research is right if you…

  • Want to work in clinical trial design or research methodology at academic or senior level.
  • Are pursuing, or considering, a PhD.
  • Need an MSc-level qualification for a specific employer or visa pathway.
  • Have 1 to 2 years and £8,000 to £25,000 to invest in the credential.

Industry-direct training is right if you…

  • Want to be working in pharma inside 6 to 9 months, not 18 to 24.
  • Are targeting regulatory medical writing, pharmacovigilance, drug safety, or a CRA route.
  • Want live mentorship from people still working in industry, not academics.
  • Would rather keep £15,000 to £20,000 than pay for a credential you may not need.

The two routes, side by side

DimensionMSc Clinical Research (UK)Industry-Direct Training (PharmaLink)
Duration12 to 24 months, full or part-time6 months total (live cohort + supervised portfolio + 1:1 mentorship)
Cost (tuition)£8,000 to £25,000+£3,499 (RMW) / £3,999 (PV bundle)
DeliveryLectures, seminars, dissertation. Mixed cohort and self-study.100% live sessions with practising industry experts. No pre-recorded library.
OutputMSc certificate + dissertationPortfolio of industry-standard deliverables + Met Standard / Distinction marking
Roles it targetsCRA, Clinical Trial Coordinator, Research Associate, PhD pathwayRegulatory Medical Writer, Pharmacovigilance Officer, Drug Safety Associate, and a stepping stone into CRA roles
Time to first industry role18 to 33 months from starting the MSc7 to 12 months from starting
Recognised credentialYes (formal MSc)CPD-accredited certificate + portfolio + references

The cost is not £4,500 versus £15,000

Once you include living costs and the income you give up to study full-time, the real gap is far wider than the tuition difference suggests.

MSc Clinical Research — true cost of ownership

Tuition £8,000–£25,000 · living costs £12,000–£18,000 · ~1 year of foregone earnings £25,000–£35,000.

£45,000 to £78,000 over the period

PharmaLink RMW — true cost of ownership

£3,499 programme fee. Delivered alongside your current role, so foregone earnings are typically £0.

£3,499 total

This does not invalidate the MSc. If the credential is what your career path requires, the cost is justified. If it is not, it is harder to defend on rational grounds.

Talk it through — book a £100 strategy call

What pharmaceutical employers actually filter for

Having hired in pharmacovigilance up to Global PV Head level, the honest order is this:

  1. Can you do the work to industry standard on day one? A portfolio of real deliverables is direct evidence — and it often beats an MSc on this dimension.
  2. Do you understand the regulatory and quality framework? Both routes teach this. One applies it to deliverables; the other teaches it conceptually. Either works if you can demonstrate it.
  3. Do you hold the credential the role specifically requires? For most industry-applied roles, no. For academic or research-methodology roles, yes. Read the job descriptions before you decide.

The common mistake is assuming the third point is the first. For most industry roles, it is not. The hiring manager wants to see you can do the work. Show them.

When the MSc is genuinely the better choice

  • Academic and translational research — trial design at protocol level, research methodology, academic medicine.
  • PhD pathway — an MSc is a standard prerequisite.
  • Specific employer or visa requirements that name an MSc-level qualification.
  • You value the academic experience in its own right — that has legitimate worth.

If one of these is you, the MSc is defensible. If none are, and you want to be working in pharma quickly, the calculation changes.

The two routes in

Both are live, cohort-based, taught by 13 industry experts still working in pharma, and marked on industry-standard criteria. Each includes unlimited 1:1 mentorship and CV & interview support until you land your first role.

Regulatory Medical Writing

£3,499
  • Clinical study reports, protocols, briefing books, investigator brochures, ICFs
  • The most common practical route toward CRA and medical-writing roles
  • 8 weeks live teaching + 16-week supported portfolio
  • References on completion
View RMW programme

Pharmacovigilance (Tier 1 & 2)

£3,999
  • Case processing, signal management, aggregate reporting, inspection readiness
  • 200-case portfolio inside the VIGILANT IQ™ training environment
  • 6 months total, live evening sessions
  • References on completion
View PV programme

Not sure which fits your background? The £497 Personalised Pharma Career Report maps your specific background to the highest-fit roles with realistic timelines and salary bands.

Built by someone who has hired for these roles

PharmaLink Academy was founded by Dorothy Ogwuru, a pharmaceutical professional with 18+ years across clinical data management, pharmacovigilance up to Global PV Head level, and regulatory medical writing. She has worked with multiple global pharmaceutical companies and mentored dozens of healthcare professionals into industry roles.

The programmes exist to close one specific gap: brilliant healthcare professionals held back not by talent, but by a lack of exposure to how the pharmaceutical industry actually operates.

Emeka — from healthcare into a pharma industry role

Common questions

Will employers respect industry-direct training as much as an MSc?

For industry-applied roles in pharmacovigilance, regulatory medical writing, and drug safety: yes, often more. A portfolio of real deliverables and a training pathway from practising professionals carries weight. For academic or trial-design roles at senior level, an MSc is the recognised credential. Decide by the role you want.

Can I do both?

Some people do. The programmes are delivered live alongside existing commitments, so you can complete the practical training during an academic year and graduate with both the credential and the portfolio.

What is the real time-to-job difference?

An MSc graduate is typically employable 18 to 33 months after starting. An industry-direct graduate is typically employable 7 to 12 months after starting. The gap matters most if you are mid-career or have financial obligations.

Is PharmaLink CPD-accredited?

Yes. The programmes are CPD-accredited and the marking criteria are aligned with what pharmaceutical sponsors hire to.

Decide with someone who has done the job

Book a £100 strategy call, credited in full against your enrolment. Dorothy or a senior team member will walk you through the route that fits your background honestly — including whether an MSc is the better choice for you.

Book a strategy call — £100 Or get the £497 Career Report
This page is independent and not affiliated with any UK university running MSc Clinical Research programmes. It is a decision aid for prospective students weighing routes into the pharmaceutical industry. Programme details and fees are accurate as of June 2026 and may change.